Key Highlights:
- Pfizer’s tablet is the first FDA-approved oral antiviral medicine intended particularly to combat Covid.
- The business stated that it is ready to begin shipping in the United States right away.
- The approval comes at a critical juncture in the pandemic, as healthcare systems across the United States have been hit by a wave of delta and omicron infections
FDA approves Pfizer’s tablet
Pfizer’s tablet is the first FDA-approved oral antiviral medicine intended particularly to combat Covid. Pfizer’s Covid therapy tablet has been given emergency approval by the Food and Drug Administration, a huge step forward in the fight against the virus.
Patients who are at a high risk of experiencing severe Covid-19 may be able to get the medicine as early as this weekend. Pfizer CEO Albert Bourla stated earlier this month that the business has already delivered some of the medicines to the United States in order for them to be given as soon as the FDA approval is received. The Centers for Disease Control and Prevention (CDC) is likely to provide a stamp of approval soon, allowing it to be distributed.
The medication has been approved by the FDA for individuals aged 12 and above who have mild to moderate Covid and are at a high risk of being hospitalized or dying. It should be given as soon as feasible following a diagnosis and no later than five days after the beginning of symptoms, according to the FDA.
Dr. Patrizia Cavazzoni, head of the FDA’s Center for Drug Evaluation and Research, stated in a statement that “today’s authorization offers the first oral therapy for COVID-19 – a critical step forward in the battle against this worldwide epidemic.” “At a critical point in the pandemic, as new variations develop, this authorization gives a new weapon to battle COVID-19, and it promises to make antiviral therapy more accessible to patients who are at high risk of progressing to severe COVID-19.”
Pfizer is ready to ship in The U.S
The business stated that it is ready to begin shipping in the United States right away.
Pfizer’s tablet is the first FDA-approved oral antiviral medicine intended particularly to combat Covid. The approval comes at a critical juncture in the pandemic, as healthcare systems across the United States have been hit by a wave of delta infections and are now preparing for another wave of patients infected with the extremely dangerous omicron form. While immunizations are the first line of protection against Covid, medicine offers a new weapon in the fight against the virus, according to the FDA. While the vaccines have been shown to be successful in avoiding serious disease from the virus, healthcare practitioners will require pharmaceuticals to treat the tens of millions of individuals in the United States who have yet to get vaccinations. If supplied in time, the tablet might help relieve the load on healthcare systems as a result of an impending surge of omicron infections.
Also Read: Is the Omicron Variant of COVID-19 Virus more deadly than the Delta Variant?
